NCT01859728 GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer Status UNKNOWN Phase PHASE2
NCT01857726 Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion Status WITHDRAWN Phase NA
NCT01855451 Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE3
NCT01849783 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01846390 Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01836341 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation Status WITHDRAWN Phase PHASE1
NCT01836029 Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01833832 Surgery and Heated Chemotherapy for Adrenocortical Carcinoma Status COMPLETED Phase PHASE2
NCT01830270 Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer Status TERMINATED Phase PHASE2
NCT01828736 Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Status COMPLETED Phase PHASE2
NCT01828099 LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01828034 First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01825603 ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer Status COMPLETED Phase PHASE1
NCT01824459 S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients Status COMPLETED Phase PHASE3
NCT01822496 Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01817023 The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT Status UNKNOWN Phase PHASE3
NCT01810913 Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Status SUSPENDED Phase PHASE2/PHASE3
NCT01809210 Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01798004 Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Status COMPLETED Phase PHASE1